Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company's board declared a dividend of Rs 30 per share and (...)
Site référencé: The Economic Times
The Economic Times
ETMarkets PMS Talk : India’s growth + global devaluation = next bull market - Qode’s FY26 outlook
23/05/2025
Liquidity abundant, but regulatory curbs holding back NBFC growth ambitions : Shweta Daptardar
23/05/2025
SEBI working with NSE to resolve pending IPO issues : Tuhin Kanta Pandey
23/05/2025
Aegis Vopak Terminals plans Rs 2,800 crore IPO to reduce debt and expand operations
23/05/2025
What's causing profit decline in major broking firms ?
23/05/2025
JSW Steel seeks refund of Bhushan Power and Steel-linked payments
23/05/2025
